pembrolizumab
merck
['tnbc']
rcb-2 have maximum benefit with adjuvant immunotherapy #kn522 #tnbc #asco22 
Breast Onc and Genetics enthusiast @BillingsClinic Opinions mine She/Her #IMG #MedEd #MedicareForAll #Oncology